Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Imaging BiometricsIQAIF EBIT per Share is $-0.00 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 527 Healthcare Providers & Services companies, Imaging Biometrics ranks better than 71.92% on this metric.
Imaging Biometrics's EBIT per Share for the
six
months ended in Dec. 2025 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.00.
During the past 3 years, the average EBIT per Share Growth Rate was 30.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 28.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 16.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Imaging Biometrics's EBIT per Share or its related term are showing as below:
IQAIF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -54.7 Med: 17 Max: 61.3
Current: 30.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Imaging Biometrics was 61.30% per year. The lowest was -54.70% per year. And the median was 17.00% per year.
IQAIF's 3-Year EBIT Growth Rate is ranked better than 71.92% of 527
companies
in the Healthcare Providers & Services industry
Industry Median: 12.1
vs IQAIF: 30.70
Imaging Biometrics (OTCPK:IQAIF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Imaging Biometrics EBIT per Share Related Terms
Imaging Biometrics EBIT per Share Historical Data
* Premium members only.
The historical data trend for Imaging Biometrics's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imaging Biometrics (IQAIF) has a EBIT per Share of $-0.00 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Imaging Biometrics and its competitors. According to the industry distribution chart, Imaging Biometrics ranks #148 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 28.1%.
Is Imaging Biometrics' EBIT per Share too high?
Imaging Biometrics' current EBIT per Share is $-0.00. Based on the distribution chart, Imaging Biometrics ranks #148 out of 527 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Imaging Biometrics' EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #148 out of 527 companies for EBIT per Share. This puts Imaging Biometrics in the upper half of its industry. The industry median EBIT per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.10, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current EBIT per Share is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current EBIT per Share of $-0.00. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current EBIT per Share is $-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current EBIT per Share is $-0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IQAIF has been successfully added to your 
